Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PROGNOSTICATION AND UPDATED HOSPICE REGULATIONS IN CARE PLANNING FOR FRAIL ELDERS Milta Oyola Little, D.O. CMD Saint Louis University Speaker Disclosures Dr. Little has disclosed that she has no relevant financial relationship(s). Dr. Little will not be discussing any off-label or unapproved medications or therapies. Objectives • By the end of the session, participants will be able to o Describe how trends in hospice utilization affect patient quality outcomes, Medicare reimbursement, and the development of models of care. o Describe the proposed demonstration projects and changes to Medicare hospice reimbursement. o List available prognostication tools to assist with clinical decision-making. ? Created By: Medical College of Wisconsin. Available at POGOe.org, Assessed 2/16/14 Medicare Hospice Benefit • Established in 1982 for high-quality end-of-life care • Eligibility o Medicare Part A o Terminal illness (6 months or less if illness runs its natural course) o Forgo intensive medical interventions of curative intent • Benefit Period o Two 90 day periods, followed by unlimited 60 day periods o Initial certification by two physicians o Recertification by hospice physician Trends in Hospice Use • In 2012, ~1.5-1.6 million patients received hospice services Hospice Care in America. NHPCO Facts and Figures, 2013 Trends in Hospice Use • Cancer diagnoses now account for less than half of all hospice admissions Hospice Care in America. NHPCO Facts and Figures, 2013 Hospice Use in the NH Miller SC, et al. JAGS 2010; 58:1482-1488 Hospice Use in the NH • • • • Better pain management Fewer hospitalizations Greater family satisfaction with care at end-of-life Lower cost across all time periods Miller SC, et al. JAGS 2010; 58:1482-1488 Kelley AS, et al. Health Affairs 2013; 32(3):552-561 Recent Changes to the Medicare Hospice Benefit Medicare is Watching You “We found that 82% of hospice claims for beneficiaries in nursing • OIG Report facilities in 2006 did not meet o Federal oversight lacking Medicare coverage requirements. o High deficiency rate Medicare paid approximately $1.8 billion for these claims. …raises concerns about the services that • NH Utilization Medicare is payingTrends for and the o Nebulous diagnoses quality of care that hospices are o Increased Medicare expenditures providing to beneficiaries during Effectiveness NH-Hospice collaborations theirolast months ofoflife.” OIG, “Medicare Hospices: Certification and Centers for Medicare & Medicaid Services Oversight,” OEI-06-05-00260, Apr 2007 OIG, “Medicare Hospice Care for Beneficiaries in Nursing Facilities: Compliance With Medicare Coverage Requirements,” OEI-02-06-00221, Sept 2009 How Reimbursement Currently Works • All-inclusive per diem rate o o o o Routine home care** General inpatient care Continuous care Respite care • Not adjusted for case-mix or NH setting • Medicare caps aggregate payments Huskamp HA, et al. Health Affairs 2010; 29(1):130-135 Hospice Care in America. NHPCO Facts and Figures, 2013 Proposed Changes to Reimbursement • Move away from flat per diem rate Active dying phase Enrollment • Consideration for different payment structure for hospice care in the nursing home (being studied) Medpac Report to the Congress. Reforming Medicare’s Hospice Benefits 2009; Chap 6:347-376 Medpac Report to the Congress. Reforming Medicare’s Hospice Benefits 2009; Chap 6:347-376 Recent Reimbursement Changes The Medicare Hospice Benefit. hospiceactionnetwork.org • Failure to meet quality reporting requirement will result in 2% reduction in 2014 Market basket update o NQF #0209: Pain Management o Participation in QAPI with >3 quality indicators related to patient care CMS Federal Register. FY2014 Hospice wage index and payment rate update 2013; 78(152):48234-48281 Recent Regulatory Changes • Brief Physician Narrative: Effective Oct 1, 2009 • Face-to-Face Encounter: Effective Jan 1, 2011 • 100% Medical Review of Certain Patients: Effective Jan 1, 2011 • Ineligible ICD-9 codes under “Symptoms, Signs and Ill-Defined Conditions” and “Mental, Behavioral and Neurodevelopmental Disorders” The Medicare Hospice Benefit. hospiceactionnetwork.org CMS Federal Register. FY2014 Hospice wage index and payment rate update 2013; 78(152):48234-48281 CMS Federal Register. FY2014 Hospice wage index and payment rate update 2013; 78(152):48234-48281 Proposed Models of Care Concurrent Care Demonstration Projects End-of-Life Benefit Concurrent Care Demonstration Curative Hospice Care 6 months Curative Hospice Care No Time Requirement ACA Sec. 3140 Medicare Hospice Concurrent Care Demonstration Program • 3-year projects • Modification of existing eligibility criteria o To reduce very short hospice stays (reduce delay in enrollment) o Test of need for palliative care without strict prognostic requirement o Greater access for certain underserved groups • To measure effects of concurrent care on cost, access, quality of care, and survival Casarett DJ. JAMA 2011; 305(10):1031-1032 ACA Sec. 3140 Medicare Hospice Concurrent Care Demonstration Program • Diagnoses o COPD, CHF, HIV/AIDS, Cancer o Fact Sheet • Limitations o NH patients not eligible o Dementia diagnoses excluded End of Life Benefit • Modified program for LTC residents o Drops 6-month prognostic requirement o Drops requirement to forgo curative treatments o Combination of palliative and psychosocial-spiritual support • Supplemental payments made directly to NH o End-of-life services “carved-in” and adjusted to need o Provide care directly or contract with local hospice o NH accountable for quality of care – quality indicators TBD • Threshold for patient eligibility TBD Huskamp HA, et al. Health Affairs 2010; 29(1):130-135 Prognostication Issues Slide used with permission, courtesy of Eric Widera, MD Dying is Individual Lynn J, Adamson DM. Living well at the end of life. Adapting health care to Lunney, J. R. etserious al. JAMA 2003;289:2387-2392 chronic illness in old age. Washington: Rand Health, 2003 What is Prognostication? Foreseeing (determining) Foretelling (relaying) Slide used with permission, courtesy of Lindy Landzaat, DO Why Prognosticate? • Hospice eligibility • Goals of care • Advanced care planning (financial, ADL) • Resource allocation • Clinical decision-making Alrawi YA, et al. Q J Med 2013; 106:51-57 Chan TC, et al. Geriatr Gerontol Int 2012; 12:555-562 Widera E, et al. JAMA 2011; 305(7):698-706. Yourman LC, et al. JAMA 2012; 307(2):182-192 Ways to Prognosticate Clinical Judgment Slide used with permission, courtesy of Eric Widera, MD Shortcomings of Clinical Predictions • Tend to overestimate patient survival by a factor of between 3 and 5. • Tend to be more accurate for very shortterm prognosis than long-term prognosis. • Influenced by relationships Christakis NA and Lamont EB. BMJ. 2000 Feb 19;320(7233):469-72 Slide used with permission, courtesy of Eric Widera, MD Ways to Prognosticate Clinical Judgment Life Tables Slide used with permission, courtesy of Eric Widera, MD Great Variation in Life Expectancy for People of Similar Ages Life Expectancy for Women 25 Top 25th Percentile 50th Percentile Lowest 25th Percentile 20 Years 15 10 5 0 70 75 80 85 90 Age (years) Walter LC. JAMA 2001;285:2750-56 Slide used with permission, courtesy of Eric Widera, MD Use Functional Status Life Expectancy (years) Age Independent Mobility disabled ADL disabled 70 16.7 15.7 11.5 75 13.2 12 8.2 80 10.3 9 6 85 8 6.9 4.6 Keeler et al. J Gerontol A Biol Sci Med Sci. 2010 Slide used with permission, courtesy of Eric Widera, MD Prognostication is more accurate if you combine clinical judgment with life tables, functional status and comorbid conditions Walter LC. JAMA 2001;285:2750-56 Christakis & Iwashyna, Arch Intern Med 1998 Keeler et al. J Gerontol A Biol Sci Med 2010 McGinn, JAMA 2000 Ways to Prognosticate Clinical Judgment Life Tables Prognostic Indices Slide used with permission, courtesy of Eric Widera, MD Prognostic Indices Physicians can use prognostic indices to lend confidence to their judgments about prognosis National survey of 697 physicians: 57% felt inadequately trained in prognostication Christakis & Iwashyna, Arch Intern Med 1998 Slide used with permission, courtesy of Eric Widera, MD • Identified 16 validated non-disease specific prognostic indices for older adults • 6 for community dwelling adults • 2 for nursing home • 8 for hospitalized patients • Results used to form ePrognosis.ucsf.edu Yourman LC, et al. JAMA 2012; 307(2):182-192 Used with permission, courtesy of Eric Widera, MD • Identified 8 risk factors • ROC 0.76 • Compared to Flacker long-stay NH index (ROC 0.73) Chan TC, et al. Geriatr Gerontol Int 2012; 12:555-562 ? Created By: Medical College of Wisconsin. Available at POGOe.org, Assessed 2/16/14 Medicare Hospice Criteria for Dementia • Stage 7 or beyond on the Functional Assessment Staging Scale (FAST) • One of the following within the past 12 mo: o o o o o o Aspiration pneumonia Pyelonephritis or other upper UTI Septicemia Decubitus ulcers, multiple, stage 3-4 Fever, recurrent after antibiotics Inability to maintain sufficient fluid and calorie intake with 10% weight loss during the previous six months or serum albumin < 2.5 • C-statistic for ADEPT 0.62-0.72 • C-statistic for Medicare hospice eligibility 0.55 Mitchell, SL, et al. JAMA 2010; 304(17):1925-1935 Prognostication: limitations • Medicare hospice criteria are guidelines, not hard and fast rules • Indices may have limited clinical utility outside of the population in which they were created • Indices based on MDS 2.0 or ICD-9 codes no longer useful as data management changes • Questionable discriminatory ability of indices Yourman LC, et al. JAMA 2012; 307(2):182-192 Used with Permission Acknowledgements • A special thank you to those who shared articles, web resources, slides and support o o o o Amy Corcoran, MD, CMD – U of Pennsylvania Eric Widera, MD – U of California San Francisco Lindy Lanzaat, DO – U of Kansas Medical Center Paul Tatum, MD – U of Missouri